Screening for prostate cancer by using random-effects models

Journal of the Royal Statistical Society. Series A: Statistics in Society

Volumn 166, Issue 1, 2003, Pages 51-62

  Brant, Larry J ^a,e   Sheng, Shan L ^a   Morrell, Christopher H ^a,b   Verbeke, Geert N ^c   Lesaffre, Emmanuel ^c   Carter, H Ballentine ^d  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b LOYOLA UNIVERSITY MARYLAND   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cancer diagnosis; Classification; Disease screening; Linear mixed effects model; Longitudinal data; Prostate specific antigen

Indexed keywords

EID: 17444422242     PISSN: 09641998     EISSN: 1467985X     Source Type: Journal    
DOI: 10.1111/1467-985X.00258     Document Type: Article

References (24)

1. Altman, D. G. and De Stavola, B. L. (1994) Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Statist. Med., 13, 301-341.
2. Bycott, P. and Taylor, J. (1998) A comparison of smoothing techniques for cd4 data measured with error in a time-dependent cox proportional hazards model. Statist. Med., 17, 2061-2077.
3. Carter, H. B. and Coffey, D. S. (1990) The prostate: an increasing medical problem. Prostate, 16, 39-48.
4. Carter, H. B. and Pearson, J. D. (1994) Evaluation of changes in PSA in the management of men with prostate cancer. Sem. Oncol., 21, 554-559.
5. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C. (1992) Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. J. Am. Med. Ass., 267, 2215-2220.
6. Catalona, W. J., Smith, D. S. and Ratliff, T. L. (1991) Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324, 1156-1161.
7. Cooner, W. H., Mosley, B. R., Rutherford, C. L., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C. and Kidd, D. D. (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination, and prostate-specific antigen. J. Urol., 143, 1146-1154.
8. Dafni, U. G. and Tsiatis, A. A. (1998) Evaluating surrogate markers of clinical outcome when measured with error. Biometrics, 54, 1445-1462.
9. De Gruttola, V. and Tu, X. M. (1994) Modeling progression of CD-4-lymphocyte count and its relationship to survival time. Biometrics, 50, 1003-1014.
10. De Stavola, B. L. and Christensen, E. (1996) Multilevel models for longitudinal variables prognostic for survival. Lifetime Data Anal., 2, 329-347.
11. Hand, D. J. (1992) Statistical methods in diagnosis. Statist. Meth. Med. Res., 1, 49-67.
12. Hogan, J. W. and Laird, N. W. (1997a) Mixture models for the joint distribution of repeated measures and event times. Statist. Med., 16, 239-257.
13. _(1997b) Model-based approaches to analyzing incomplete longitudinal and failure time data. Statist. Med., 16, 259-272.
14. Morrell, C. H., Pearson, J. D., Carter, H. B. and Brant, L. J. (1995) Estimating unknown transition times using a piecewise nonlinear mixed-effects model in men with prostate cancer. J. Am. Statist. Ass., 90, 45-53.
15. Pearson, J. D., Morrell, C. H., Landis, P. K., Carter, H. B. and Brant, L. J. (1994) Mixed-effects regression models for studying the natural history of prostate disease. Statist. Med., 13, 587-601.
16. Pisani, P., Parkin, D. M., Bray, F. and Ferlay, J. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29.
17. Shock, N. W., Greulich, R. C., Andres, R., Lakatta, E. G., Arenberg, D. and Tobin, J. D. (1984) Normal human aging: the Baltimore Longitudinal Study of Aging. Publication 84-2450. National Institutes of Health, Washington DC.
18. Stamey, T. A. and Kabalin, J. N. (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate, I: untreated patients. J. Urol., 141, 1070-1075.
19. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S. and Redwine, E. (1987) Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl. J. Med., 317, 909-916.
20. Tsiatis, A. A., De Gruttola, V. and Wulfsohn, M. S. (1995) Modeling the relationship of survival to longitudinal data measures with error: applications to survival and CD4 counts in patients with AIDS. J. Am. Statist. Ass., 90, 27-37.
21. Wang, M. C., Valenzuela, L. A., Murphy, G. P. and Chu, T. M. (1979) Purification of a human prostate specific antigen. Invest. Urol., 17, 159-163.
22. Wulfsohn, M. S. and Tsiatis, A. A. (1997) A joint model for survival and longitudinal data measured with error. Biometrics, 53, 330-339.
23. Xu, J. and Zeger, S. L. (2001) Joint analysis of longitudinal data comprising repeated measures and times to events. Appl. Statist., 50, 375-387.
24. Zelen, M. and Feinleib, M. (1969) On the theory of screening for chronic disease. Biometrika, 56, 601-614.